IT-DIAB
DEAD

Serial Number

77834075

Owner

GENFIT

Attorney

Brooks R. Bruneau

Filing Date

Sep 24, 2009

Add to watchlist:

No watchlists yet
View on USPTO

IT-DIAB Trademark

Serial Number: 77834075 • Registration: 3906325

IT-DIAB is a trademark filed by GENFIT on September 24, 2009. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

GENFIT (44 trademarks)

885 rue Eugene Avinee
Loos 59120 , FR

Entity Type: 03

Trademark Details

Filing Date

September 24, 2009

Registration Date

January 18, 2011

Published for Opposition

November 2, 2010

Cancellation Date

August 25, 2017

Goods & Services

Downloadable electronic databases and files and computer programs for retrieving, compiling, integrating and sending data relating to research on type II diabetes, prediabetes and their associated acute or chronic complications in particular experimental data concerning the targets, biomarkers, cellular models and animals which are being used or developed; Downloadable electronic databases and files and computer programs for retrieving, compiling, integrating and sending data relating to methods for the preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Downloadable electronic databases and files and computer programs for retrieving, compiling, integrating and sending medical data relating to the condition of patients monitored for the preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complication

Pharmaceutical preparations and substances for medical use for the preventive or curative treatment of type II diabetes, of pre diabetes and their acute or chronic complications; Active principles used against type II diabetes, pre diabetes and their acute or chronic complications; Preparations for medical use with bio markers and cellular models for the in vivo, ex vivo or in vitro diagnosis of type II diabetes and of pre diabetes and their associated acute or chronic complications; Preparations for medical use with bio markers and cellular models for the medical follow-up of patients at risk or of patients suffering from type II diabetes, pre diabetes and their associated acute or chronic complications; Preparations for medical use for bio markers and cellular models for the selection and assessment of drugs and their compounds for their preventive and curative properties towards type II diabetes, pre diabetes and their associated acute or chronic complications

Scientific research and information in the field of prevention, diagnosis, screening, preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Scientific research, in particular clinical research on the assessment of the effects of drugs and their compounds having preventive or curative properties of type II diabetes, prediabetes and their acute or chronic complications; Development and validation of tests for the diagnosis and medical follow-up of patients at risk or of patients suffering from type II diabetes, prediabetes and/or their associated acute or chronic complications; Development and validation of biological tests in vitro, ex vivo and in vivo for sorting and selecting compounds, products and substances intended for the preventive or curative treatment of type II diabetes, prediabetes and their associated acute or chronic complications

Filing History

CANCELLED SEC. 8 (6-YR)
Aug 25, 2017 C8..
REGISTERED-PRINCIPAL REGISTER
Jan 18, 2011 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 2, 2010 NPUB
PUBLISHED FOR OPPOSITION
Nov 2, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 28, 2010 PREV
ASSIGNED TO LIE
Sep 28, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2010 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 20, 2010 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 20, 2010 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 20, 2010 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 20, 2010 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 20, 2010 GNRN
NON-FINAL ACTION E-MAILED
Apr 20, 2010 GNRT
NON-FINAL ACTION WRITTEN
Apr 20, 2010 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 8, 2010 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 29, 2010 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 12, 2010 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 12, 2010 CNSA
AMENDMENT FROM APPLICANT ENTERED
Mar 11, 2010 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 11, 2010 CRFA
ASSIGNED TO LIE
Mar 11, 2010 ALIE
PAPER RECEIVED
Feb 22, 2010 MAIL
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 28, 2009 GNRN
NON-FINAL ACTION E-MAILED
Dec 28, 2009 GNRT
NON-FINAL ACTION WRITTEN
Dec 28, 2009 CNRT
ASSIGNED TO EXAMINER
Dec 21, 2009 DOCK
NOTICE OF PSEUDO MARK MAILED
Sep 30, 2009 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2009 NWOS
NEW APPLICATION ENTERED
Sep 28, 2009 NWAP